An interventional study of REBOA in Cardiac Arrest, sponsored by neurescue. Withdrawn. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2021-05-04.
Sponsored by neurescue · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Cardiac arrest is a major health problem that carries a high mortality rate. Substantial research and development have been put into changing the outcome of cardiac arrest and despite the advent of automated external defibrillators (AED), increase in bystander Cardiopulmonary resuscitation (CPR) and automated CPR devices (ACPR), the proportion of patient survival to hospital discharge has only minimally improved.
The objective is to investigate safety and performance of the Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) procedure as an adjunct to Advanced Life Support (ALS) for treatment of refractory cardiac arrest.
The scope of the study is to collect data on patients with refractory out of hospital cardiac arrest (OHCA) for this feasibility study.
Data collected:
The investigation is initiated to investigate the safety and performance of the REBOA procedure for patients experiencing refractory OHCA.
927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.
Browse Heart Arrest studies →neurescue is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.
Relapsed and refractory
Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Procedure: REBOA
Endovascular balloon occlusion of the aorta
Central blood pressure
Time frame: 1 hour
Return of spontaneous circulation (ROSC)
Time frame: 1 hour
Changes in cardiac rhythm following balloon inflation
Time frame: 1 hour
During procedure - time from first needle stick to successful sheath insertion
Time frame: 1 hour
During procedure - time from first needle stick to finalized balloon inflation
Time frame: 1 hour
End-tidal CO2 (EtCO2)
Time frame: 1 hour
No study locations are listed for this record.
Plan to share: No — Individual request
No publications or documents are linked to this record.
Start is estimated for Nov 2020; primary completion for Nov 2020, 0 months later.
How these figures are worked out, and which studies are left out of them.
This study is withdrawn, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
neurescue